Has Abraham Hakimi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,646 in general payments to Abraham Hakimi, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abraham Hakimi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abraham Hakimi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abraham Hakimi, MD

Urology · New York, NYNPI 1477793917

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,500 of the $1,646 with a category attached, or 91.1%. Merck accounts for 91.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $1,511 and has fallen 96.6% since, to $51 in 2025. That places this record below the midpoint for urology clinicians in NY, where the typical reported total is $2,467.

$1,646in general payments, 2019–2025

Across 5 payments — averaging $329.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$2K
Rochester Medical Corporation$84
Ceribell, Inc.$51

$375,000in research payments, 2019–2025

Across 2 payments — averaging $187,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$375K

What the payments were for

Consulting fees$1,50091%
Food & beverage$513%
Education$956%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	2	$1,511
Rochester Medical Corporation	2	$84
Ceribell, Inc.	1	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WELIREG$1,500

How this compares

$1,646 in reported general payments places this provider in the 40th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$123,200

Medicare patients

285

Services billed

621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	32	$402

Paid to pharmacies, not to this prescriber.

Other urology in New York

Bilal ChughtaiNew York$658K
Katie MurrayNew York$575K
Neil BanderNew York$544K
Robert ValenzuelaNew York$494K
Kyrollis AttallaNew York$381K
Benjamin BruckerNew York$364K
Ketan BadaniNew York$285K
Michael GrassoNew York$284K
Mantu GuptaNew York$229K
Robin SmithNew York$215K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →